Yesterday, May 26, 2016, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $0.02 to $20,083,643.73.

Highlighted Stocks Traded by Insiders:

HubSpot (HUBS) - FREE Research Report

Skok David R, who is Director at HubSpot, sold 11,005 shares at $45.58 on May 26, 2016. Following this transaction, the Director owned 15,445 shares meaning that the stake was reduced by 41.61% with the 11,005-share transaction.

The shares most recently traded at $46.09, up $0.51, or 1.1% since the insider transaction. Historical insider transactions for HubSpot go as follows:

  • 4-Week # shares sold: 8,300
  • 12-Week # shares sold: 32,500
  • 24-Week # shares sold: 163,200

The average volume for HubSpot has been 376,000 shares per day over the past 30 days. HubSpot has a market cap of $1.6 billion and is part of the technology sector and computer software & services industry. Shares are down 18.88% year-to-date as of the close of trading on Thursday.

HubSpot, Inc. provides a cloud-based marketing and sales software platform for businesses in the Americas, Europe, and the Asia Pacific. Currently, there are 5 analysts who rate HubSpot a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HUBS - FREE

TheStreet Quant Ratings rates HubSpot as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full HubSpot Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MaxLinear (MXL) - FREE Research Report

Kwong Connie H., who is Corporate Controller & PAO at MaxLinear, sold 3,796 shares at $19.99 on May 26, 2016. Following this transaction, the Corporate Controller & PAO owned 0 shares meaning that the stake was reduced by 100% with the 3,796-share transaction.

The shares most recently traded at $20.25, up $0.26, or 1.27% since the insider transaction. Historical insider transactions for MaxLinear go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 27,500
  • 24-Week # shares sold: 27,500

The average volume for MaxLinear has been 1.4 million shares per day over the past 30 days. MaxLinear has a market cap of $1.3 billion and is part of the technology sector and electronics industry. Shares are up 36.25% year-to-date as of the close of trading on Thursday.

MaxLinear, Inc. provides integrated, radio-frequency (RF) and mixed-signal circuits for broadband communication and data center, metro, and long-haul transport network applications worldwide. Currently, there are 7 analysts who rate MaxLinear a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MXL - FREE

TheStreet Quant Ratings rates MaxLinear as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, increase in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full MaxLinear Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings (HCA) - FREE Research Report

Yuspeh Alan R, who is SVP & Chief Ethics Officer at HCA Holdings, sold 15,000 shares at $77.82 on May 26, 2016. Following this transaction, the SVP & Chief Ethics Officer owned 37,228 shares meaning that the stake was reduced by 28.72% with the 15,000-share transaction.

The shares most recently traded at $77.50, down $0.32, or 0.42% since the insider transaction. Historical insider transactions for HCA Holdings go as follows:

  • 4-Week # shares bought: 4,000
  • 4-Week # shares sold: 2,388
  • 12-Week # shares bought: 4,000
  • 12-Week # shares sold: 2,388
  • 24-Week # shares bought: 4,000
  • 24-Week # shares sold: 2,388

The average volume for HCA Holdings has been 3.0 million shares per day over the past 30 days. HCA Holdings has a market cap of $30.4 billion and is part of the health care sector and health services industry. Shares are up 14.15% year-to-date as of the close of trading on Thursday.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. The company has a P/E ratio of 14.6. Currently, there are 15 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCA - FREE

TheStreet Quant Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.